"Acute Limb Ischemia: A Two Pronged Approach"

Title: Acute Limb Ischemia: A Two Pronged Approach
Acute Limb Ischemia remains a morbid and deadly diagnosis, with a 1-year amputation free survival rate of 50-60%. Postoperative medication regimen consists of long term anticoagulation in patients with embolic disease, but is poorly defined in patients with acute on chronic disease. In the era of personalized medicine, novel strategies are emerging to characterize bleeding and clotting risks, such as TEG. In our proposed study, we hope to prospectively use TEG to characterize risk of thrombotic outcomes. 
More recently, percutaneous thrombectomy catheters have been developed and have shown promising preliminary results, but have not been compared to open surgical thrombectomy. We will show preliminary data from the national inpatient sample on outcomes after open versus percutaneous thrombectomy for acute limb ischemia.
Mentors: Edith Tzeng, MD and Katie Reitz, MD